Provider-Estimated Prevalence of Traditional Cigarettes, Marijuana, Synthetic Marijuana, E-Cigarettes/ENDS, NRT, and Smoking Cessation Medications (N = 417)
| Survey Question | Response Options, No. (%) | |||||
|---|---|---|---|---|---|---|
| None (0%) | Very Few (1% to 5%) | Some (6% to 25%) | Many (≥26%)* | Don’t Know | P | |
| Pregnant patients <18 years† | 12 (3) | 144 (36) | 216 (54) | 25 (6) | 0 (0) | <.0001 |
| How many pregnant patients use‡ | ||||||
| Traditional cigarettes | 4 (1) | 122 (31) | 212 (54) | 45 (12) | 8 (2) | <.0001 |
| Marijuana | 10 (3) | 120 (31) | 190 (49) | 38 (10) | 33 (8) | <.0001 |
| Synthetic marijuana§ | 54 (14) | 88 (23) | 21 (5) | 1 (0) | 227 (58) | <.0001 |
| E-cigarettes (or other ENDS) | 46 (12) | 143 (37) | 92 (24) | 3 (1) | 107 (27) | <.0001 |
| NRT‖ | 70 (18) | 174 (45) | 80 (20) | 1 (0) | 66 (17) | <.0001 |
| Medications for smoking cessation¶ | 141 (36) | 145 (37) | 38 (10) | 1 (0) | 65 (17) | <.0001 |
Where numbers do not add up to 417, the remainder represent missing data.
↵* The response categories of “Many (26% to 50%)” and “Most (>50%)” were collapsed due to low endorsement (n < 5) of the “Most (>50%)” category for all survey items.
↵† “How many of your pregnant patients are <18 years of age?”
↵‡ The full stem was, “In your practice, please estimate how many pregnant patients use the following:”
↵§ The full stem was, “Synthetic marijuana (e.g., K2, Spice).”
↵‖ The full stem was, “Nicotine replacement therapy (e.g., patches, gum, lozenges, nasal spray, or inhaler).”
↵¶ The full stem was, “Medication for smoking cessation (Bupropion [Zyban] or Varenicline[Chantix]).”
ENDS, electronic nicotine delivery systems; NRT, nicotine-replacement therapy.